Observational Study
Copyright ©The Author(s) 2025.
World J Psychiatry. Sep 19, 2025; 15(9): 109858
Published online Sep 19, 2025. doi: 10.5498/wjp.v15.i9.109858
Figure 1
Figure 1 Box plots of intergroup comparisons of thyroid hormone concentrations between groups with different disease duration. aP < 0.017. A: Triiodothyronine concentrations; B: Free triiodothyronine concentrations; C: Thyroxine concentrations; D: Free thyroxine concentrations; E: Thyroid stimulating hormone concentrations, each compared across the three groups. TSH: Thyroid stimulating hormone; T3: Triiodothyronine; FT3: Free triiodothyronine; T4: Thyroxine; FT4: Free thyroxine.
Figure 2
Figure 2 Scatter plots of thyroid hormone levels vs Positive and Negative Syndrome Scale subscale scores, showing unadjusted data and standardized residuals. A: Triiodothyronine (T3): Unadjusted; B: T3: Standardized residuals; C: Thyroxine (T4): Unadjusted; D: T4: Standardized residuals; E: Free T3: Unadjusted; F: Free T3: Standardized residuals; G: Free T4: Unadjusted; H: Free T4: Standardized residuals; I: Thyroid stimulating hormone: Unadjusted; J: Thyroid stimulating hormone: Standardized residuals. TSH: Thyroid stimulating hormone; T3: Triiodothyronine; FT3: Free triiodothyronine; T4: Thyroxine; FT4: Free thyroxine; PANSS: Positive and Negative Syndrome Scale.